High-throughput insertional mutagenesis screens in mice to identify oncogenic networks (original) (raw)

• Uren, A. G., Kool, J., Berns, A. & van Lohuizen, M. Retroviral insertional mutagenesis: past, present and future. Oncogene 24, 7656–7672 (2005). This review provides an historical overview of retroviral insertional mutagenesis screens and the different mechanisms in which genes can be mutated by retroviral integrations.
  Article CAS Google Scholar
• Jonkers, J. & Berns, A. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim. Biophys. Acta 1287, 29–57 (1996).
  PubMed Google Scholar
• Uren, A. G. et al. Large-scale mutagenesis in p19ARF- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 133, 727–741 (2008).
  Article CAS Google Scholar
• Jonkers, J., Korswagen, H. C., Acton, D., Breuer, M. & Berns, A. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas. EMBO J. 16, 441–450 (1997).
  Article CAS Google Scholar
• Nihrane, A., Fujita, K., Willey, R., Lyu, M. S. & Silver, J. Murine leukemia virus envelope protein in transgenic-mouse serum blocks infection in vitro. J. Virol. 70, 1882–1889 (1996).
  CAS PubMed PubMed Central Google Scholar
• Ikeda, H. & Sugimura, H. Fv-4 resistance gene: a truncated endogenous murine leukemia virus with ecotropic interference properties. J. Virol. 63, 5405–5412 (1989).
  CAS PubMed PubMed Central Google Scholar
• Ott, D. & Rein, A. Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU. J. Virol. 66, 4632–4638 (1992).
  CAS PubMed PubMed Central Google Scholar
• Heidmann, T., Heidmann, O. & Nicolas, J. F. An indicator gene to demonstrate intracellular transposition of defective retroviruses. Proc. Natl Acad. Sci. USA 85, 2219–2223 (1988).
  Article CAS Google Scholar
• Tchenio, T. & Heidmann, T. Defective retroviruses can disperse in the human genome by intracellular transposition. J. Virol. 65, 2113–2118 (1991).
  CAS PubMed PubMed Central Google Scholar
• Dzuris, J. L., Zhu, W., Kapkov, D., Golovkina, T. V. & Ross, S. R. Expression of mouse mammary tumour virus envelope protein does not prevent superinfection in vivo or in vitro. Virology 263, 418–426 (1999).
  Article CAS Google Scholar
• Suzuki, T., Minehata, K., Akagi, K., Jenkins, N. A. & Copeland, N. G. Tumour suppressor gene identification using retroviral insertional mutagenesis in _Blm_-deficient mice. EMBO J. 25, 3422–3431 (2006).
  Article CAS Google Scholar
• Suzuki, T. et al. New genes involved in cancer identified by retroviral tagging. Nature Genet. 32, 166–174 (2002). An elegant study in which a hypomorphic Blm allele is used to induce LOH of retrovirally inactivated tumour suppressor genes.
  Article CAS Google Scholar
• Stewart, M. et al. Insertional mutagenesis reveals progression genes and checkpoints in MYC/Runx2 lymphomas. Cancer Res. 67, 5126–5133 (2007).
  Article CAS Google Scholar
• Mikkers, H. et al. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nature Genet. 32, 153–159 (2002).
  Article CAS Google Scholar
• Erkeland, S. J. et al. Large-scale identification of disease genes involved in acute myeloid leukemia. J. Virol. 78, 1971–1980 (2004).
  Article CAS Google Scholar
• Lund, A. H. et al. Genome-wide retroviral insertional tagging of genes involved in cancer in _Cdkn2a_-deficient mice. Nature Genet. 32, 160–165 (2002).
  Article CAS Google Scholar
• Theodorou, V. et al. MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer. Nature Genet. 39, 759–769 (2007). The first large-scale MMTV insertional mutagenesis screen to identify new cancer genes in mammary tumours.
  Article CAS Google Scholar
• Kim, R. et al. Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J. Virol. 77, 2056–2062 (2003).
  Article CAS Google Scholar
• Hasemann, M. S. et al. Mutation of C/EBPα predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen. Blood 111, 4309–4321 (2008).
  Article CAS Google Scholar
• Shendure, J. & Ji, H. Next-generation DNA sequencing. Nature Biotechnol. 26, 1135–1145 (2008). An introduction to, and overview of, next-generation massive parallel sequencing technologies.
  Article CAS Google Scholar
• Dupuy, A. J., Akagi, K., Largaespada, D. A., Copeland, N. G. & Jenkins, N. A. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436, 221–226 (2005).
  Article CAS Google Scholar
• Collier, L. S., Carlson, C. M., Ravimohan, S., Dupuy, A. J. & Largaespada, D. A. Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 436, 272–276 (2005). The first two papers, which were published back-to-back, to report transposon mutagenesis systems that efficiently induce tumours in mice.
  Article CAS Google Scholar
• Carlson, C. M. & Largaespada, D. A. Insertional mutagenesis in mice: new perspectives and tools. Nature Rev. Genet. 6, 568–580 (2005).
  Article CAS Google Scholar
• Keng, V. W. et al. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nature Biotechnol. 27, 264–274 (2009).
  Article CAS Google Scholar
• Starr, T. K. et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323, 1747–1750 (2009).
  Article CAS Google Scholar
• Beverly, L. J., Felsher, D. W. & Capobianco, A. J. Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression. Cancer Res. 65, 7159–7168 (2005).
  Article CAS Google Scholar
• Beverly, L. J. & Capobianco, A. J. Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in NotchIC-induced T cell leukemogenesis. Cancer Cell 3, 551–564 (2003).
  Article CAS Google Scholar
• Iwasaki, M. et al. Identification of cooperative genes for NUP98–HOXA9 in myeloid leukemogenesis using a mouse model. Blood 105, 784–793 (2005).
  Article CAS Google Scholar
• Castilla, L. H. et al. Identification of genes that synergize with Cbfb–MYH11 in the pathogenesis of acute myeloid leukemia. Proc. Natl Acad. Sci. USA 101, 4924–4929 (2004).
  Article CAS Google Scholar
• Feldman, B. J., Reid, T. R. & Cleary, M. L. Pim1 cooperates with E2a–Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice. Oncogene 15, 2735–2742 (1997).
  Article CAS Google Scholar
• Slape, C. et al. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98_–_HOXD13 during leukemic transformation. Cancer Res. 67, 5148–5155 (2007).
  Article CAS Google Scholar
• Li, J. et al. Leukaemia disease genes: large-scale cloning and pathway predictions. Nature Genet. 23, 348–353 (1999).
  Article CAS Google Scholar
• Erkeland, S. J. et al. Significance of murine retroviral mutagenesis for identification of disease genes in human acute myeloid leukemia. Cancer Res. 66, 622–626 (2006).
  Article CAS Google Scholar
• Adams, J. M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533–538 (1985).
  Article CAS Google Scholar
• Ellwood-Yen, K. et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumours. Cancer Cell 4, 223–238 (2003).
  Article CAS Google Scholar
• Jacobs, J. J. et al. Bmi-1 collaborates with c-Myc in tumourigenesis by inhibiting c-Myc- induced apoptosis via INK4a/ARF. Genes Dev. 13, 2678–2690 (1999).
  Article CAS Google Scholar
• van der Lugt, N. M. et al. Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J. 14, 2536–2544 (1995).
  Article CAS Google Scholar
• Soucek, L. et al. Modelling Myc inhibition as a cancer therapy. Nature 455, 679–683 (2008).
  Article CAS Google Scholar
• Lazo, P. A., Lee, J. S. & Tsichlis, P. N. Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas. Proc. Natl Acad. Sci. USA 87, 170–173 (1990).
  Article CAS Google Scholar
• Hickson, I. D. RecQ helicases: caretakers of the genome. Nature Rev. Cancer 3, 169–178 (2003).
  Article CAS Google Scholar
• Luo, G. et al. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nature Genet. 26, 424–429 (2000).
  Article CAS Google Scholar
• Garrett-Engele, C. M. et al. A mechanism misregulating p27 in tumours discovered in a functional genomic screen. PLoS Genet. 3, e219 (2007).
  Article Google Scholar
• Tsihlias, J., Kapusta, L. & Slingerland, J. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu. Rev. Med. 50, 401–423 (1999).
  Article CAS Google Scholar
• Park, M. S. et al. p27 and Rb are on overlapping pathways suppressing tumourigenesis in mice. Proc. Natl Acad. Sci. USA 96, 6382–6387 (1999).
  Article CAS Google Scholar
• Pinkel, D. & Albertson, D. G. Array comparative genomic hybridization and its applications in cancer. Nature Genet. 37, S11–S17 (2005).
  Article CAS Google Scholar
• Carrasco, D. R. et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 9, 313–325 (2006).
  Article CAS Google Scholar
• Wood, L. D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108–1113 (2007). A paper describing mutations that were identified by sequencing a panel of human breast cancers. Multiple genes that are mutated in humans were also found to be CISs in MMTV-induced tumours in mice.
  Article CAS Google Scholar
• Sjoblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268–274 (2006).
  Article Google Scholar
• Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008).
  Article CAS Google Scholar
• Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801–1806 (2008).
  Article CAS Google Scholar
• Fujino, Y., Ohno, K. & Tsujimoto, H. Molecular pathogenesis of feline leukemia virus-induced malignancies: insertional mutagenesis. Vet. Immunol. Immunopathol. 123, 138–143 (2008).
  Article CAS Google Scholar
• Kanter, M. R., Smith, R. E. & Hayward, W. S. Rapid induction of B-cell lymphomas: insertional activation of c-myb by avian leukosis virus. J. Virol. 62, 1423–1432 (1988).
  CAS PubMed PubMed Central Google Scholar
• van Agthoven, T. et al. Functional identification of genes causing estrogen independence of human breast cancer cells. Breast Cancer Res. Treat. 114, 23–30 (2009).
  Article Google Scholar
• Dorssers, L. C., van, A. T., Dekker, A., van Agthoven, T. L. & Kok, E. M. Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site. Mol. Endocrinol. 7, 870–878 (1993). These authors demonstrate that insertional mutagenesis can be used to screen for genes that confer resistance to therapeutic agents in vivo.
  CAS PubMed Google Scholar
• van der, F. S. et al. Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment. J. Natl Cancer Inst. 92, 120–127 (2000).
  Article Google Scholar
• Miething, C. et al. Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment. Proc. Natl Acad. Sci. USA 104, 4594–4599 (2007).
  Article CAS Google Scholar
• Johansson, F. K., Goransson, H. & Westermark, B. Expression analysis of genes involved in brain tumour progression driven by retroviral insertional mutagenesis in mice. Oncogene 24, 3896–3905 (2005).
  Article CAS Google Scholar
• Hanai, S. et al. Integration of human T-cell leukemia virus type 1 in genes of leukemia cells of patients with adult T-cell leukemia. Cancer Sci. 95, 306–310 (2004).
  Article CAS Google Scholar
• Killebrew, D. & Shiramizu, B. Pathogenesis of HIV-associated non-Hodgkin lymphoma. Curr. HIV Res. 2, 215–221 (2004).
  Article CAS Google Scholar
• Thrasher, A. J. et al. Gene therapy: X-SCID transgene leukaemogenicity. Nature 443, E5–E6; discussion E6–E7 (2006).
  Article Google Scholar
• de Ridder, J., Uren, A., Kool, J., Reinders, M. & Wessels, L. Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens. PLoS Comput. Biol. 2, e166 (2006).
  Article Google Scholar
• Wu, X., Li, Y., Crise, B. & Burgess, S. M. Transcription start regions in the human genome are favored targets for MLV integration. Science 300, 1749–1751 (2003).
  Article CAS Google Scholar
• Berry, C., Hannenhalli, S., Leipzig, J. & Bushman, F. D. Selection of target sites for mobile DNA integration in the human genome. PLoS Comput. Biol. 2, e157 (2006).
  Article Google Scholar
• Lewinski, M. K. et al. Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2, e60 (2006).
  Article Google Scholar
• Mitchell, R. S. et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2, e234 (2004).
  Article Google Scholar
• Felice, B. et al. Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. PLoS ONE 4, e4571 (2009).
  Article Google Scholar
• Sauvageau, M. et al. Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type specific cancer genes in leukemia. Blood 111, 790–799 (2008).
  Article CAS Google Scholar
• Su, Q. et al. A DNA transposon-based approach to validate oncogenic mutations in the mouse. Proc. Natl Acad. Sci. USA 105, 19904–19909 (2008).
  Article CAS Google Scholar
• Wilson, M. H., Coates, C. J. & George, A. L. Jr. PiggyBac transposon-mediated gene transfer in human cells. Mol. Ther. 15, 139–145 (2007).
  Article CAS Google Scholar
• Carlson, C. M. et al. Transposon mutagenesis of the mouse germline. Genetics 165, 243–256 (2003).
  CAS PubMed PubMed Central Google Scholar
• van Lohuizen, M., Breuer, M. & Berns, A. N-myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas. EMBO J. 8, 133–136 (1989).
  Article CAS Google Scholar
• Girard, L. & Jolicoeur, P. A full-length Notch1 allele is dispensable for transformation associated with a provirally activated truncated Notch1 allele in Moloney MuLV-infected MMTVD/myc transgenic mice. Oncogene 16, 517–522 (1998).
  Article CAS Google Scholar
• Weng, A. P. et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269–271 (2004).
  Article CAS Google Scholar
• Yang, L. T. et al. Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1. Mol. Biol. Cell 16, 927–942 (2005).
  Article CAS Google Scholar
• Haines, N. & Irvine, K. D. Glycosylation regulates Notch signalling. Nature Rev. Mol. Cell Biol. 4, 786–797 (2003).
  Article CAS Google Scholar
• Moloney, D. J. et al. Fringe is a glycosyltransferase that modifies Notch. Nature 406, 369–375 (2000).
  Article CAS Google Scholar
• Largaespada, D. A., Shaughnessy, J. D. Jr, Jenkins, N. A. & Copeland, N. G. Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels. J. Virol. 69, 5095–5102 (1995).
  CAS PubMed PubMed Central Google Scholar
• Cho, B. C. et al. Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas. J. Virol. 69, 7138–7146 (1995).
  CAS PubMed PubMed Central Google Scholar